Wed. Jun 29th, 2022

(Natural News) Vaccine manufacturer Pfizer last month withdrew the emergency use authorization (EUA) application for its Wuhan coronavirus (COVID-19) vaccine in India. The New York-based firm’s withdrawal followed its refusal to conduct a domestic safety trial for its vaccine, which India’s drug regulator required. Pfizer decided to rescind its EUA application in India during a Feb. 2…

Read More